• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

GSW Worldwide Named Agency of Record for BioBehavioral Diagnostics Company's MMAT/ADHD(TM) System

Posted on: Friday, 2 November 2007, 15:00 CDT

COLUMBUS, Ohio, Nov. 2 /PRNewswire/ -- GSW Worldwide, an inVentiv Health company and one of the largest healthcare advertising agencies in the world, has been named agency of record by BioBehavioral Diagnostics Company (BioBDx) for their McLean Motion and Attention Test (MMAT/ADHD(TM) System), a non-invasive, diagnostic system that provides evidence-based measures of the core symptoms of Attention Deficit Hyperactivity Disorder (ADHD).

GSW Worldwide will provide a broad range of strategic marketing and promotional services for the product including the development of a new campaign, and physician programming. The account will be based in GSW Worldwide's Newtown office. The details of the contract were not disclosed.

"We are thrilled to be working with BioBDx on such an important ADHD testing system," said Mark Frank, president of GSW Worldwide's Newtown operations. "ADHD affects so many people, both patients and caregivers alike. We are confident that GSW Worldwide will help the MMAT/ADHD(TM) System team connect with all of their customers in a positive way and take this product to the next level."

The MMAT/ADHD(TM) test objectively and quantitatively measures the three core symptoms of ADHD (inattention, hyperactivity and impulsivity), gauging a patient's ability to sit still and pay attention to a defined task, under controlled conditions that replicate a classroom or workplace environment. Research data shows that the information generated by the MMAT/ADHD(TM) System correlates to brain function as determined by functional magnetic resonance imaging (MRI).

"We are very excited to work with GSW Worldwide," said Stephen E. Butts, vice president, marketing and sales at BioBehavioral Diagnostics Company. "We look forward to developing a successful and long-lasting relationship with GSW and leveraging their talents and expertise to create an effective and memorable campaign for the MMAT/ADHD(TM) System."

About BioBDx

BioBehavioral Diagnostics Company (BioBDx), an innovator in diagnostic systems for Attention Deficit Hyperactivity Disorder (ADHD), is a privately held company whose mission is to develop, manufacture, and market proprietary diagnostic systems for the quantitative assessment of behavioral and neurobiological disorders. For more information on BioBDx, please visit http://www.biobdx.com/.

About GSW Worldwide

Headquartered in Columbus, Ohio, GSW Worldwide is one of the largest healthcare advertising agencies in the world with offices in 13 major global markets. Named 2007 "Agency of the Year" by Med Ad News, GSW Worldwide provides liberating ideas(SM) that generate new energy around products, build stronger connections with customers and create leadership brands. For more information about GSW Worldwide, please go to http://www.gsw-w.com/.

About inVentiv Health

inVentiv Health, Inc. is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 250 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit http://www.inventivhealth.com/.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause Ventiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by Ventiv Health, Inc. with the Securities and Exchange Commission for further discussion of these and other factors.

GSW Worldwide

CONTACT: Investors-Corporate, David Bassin, CFO, +1-732-537-4804,investor@inventivhealth.com, or Media, Dawn Marinacci, +1-614-543-6787,dmarinacci@inventivhealth.com, both of inVentiv Health, Inc.

Web site: http://www.inventivhealth.com/http://www.biobdx.com/http://www.gsw-w.com/

Source: PRNewswire

More News in this Category